Table 1.
Demographic and Clinical Variables of Study Participants (%)
| BDS (n = 25) |
ADS (n = 26) |
Total (n = 51) |
|
|---|---|---|---|
| Race | |||
| African-American | 2 (8.0) | 1 (3.8) | 3 (5.9) |
| White | 23 (92.0) | 25 (96.2) | 48 (94.1) |
| Marital status | |||
| Single/divorced/widowed | 9 (36.0) | 4 (15.4) | 13 (25.5) |
| Married | 16 (64.0) | 22 (84.6) | 38 (74.5) |
| Age at diagnosis | |||
| <40 | 8 (32.0) | 3 (11.5) | 11 (21.6) |
| 40–49 | 11 (44.0) | 12 (46.2) | 23 (45.1) |
| 50+ | 6 (24.0) | 11 (42.3) | 17 (33.3) |
| Education | |||
| High school | 4 (16.0) | 2 (7.7) | 6 (11.8) |
| Some college/technical school | 10 (40.0) | 14 (53.9) | 24 (47.1) |
| >College | 11 (44.0) | 10 (38.4) | 21 (41.1) |
| Employment status | |||
| Not employed | 9 (36.0) | 8 (30.8) | 17 (33.3) |
| Full/part-time employed | 12 (48.0) | 13 (50.0) | 25 (49.0) |
| Other | 4 (16.0) | 5 (19.2) | 9 (17.7) |
| Stage | |||
| Ductal carcinoma in situ | 4 (16.0) | 5 (19.2) | 9 (17.6) |
| Stage 1 | 3 (12.0) | 1 (3.8) | 4 (7.8) |
| Stage 2 | 10 (40.0) | 13 (50.0) | 23 (45.1) |
| Stage 3 | 8 (32.0) | 7 (26.9) | 15 (29.4) |
| Subsequently had GT | |||
| Yes | 21 (84.0) | 17 (65.3) | 38 (74.5) |
| No | 3 (12.0) | 6 (23.1) | 9 (17.6) |
| Unknown | 1 (4.0) | 3 (11.5) | 4 (7.3) |
| FDR has breast or ovarian cancer | |||
| Yes | 9 (36.0) | 6 (23.1) | 15 (29.4) |
| No | 16 (64.0) | 20 (76.9) | 36 (70.6) |
BDS, before definitive surgery; ADS, after definitive surgery.